Erythromycin-felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice

被引:90
作者
Bailey, DG [1 ]
Bend, JR [1 ]
Arnold, JMO [1 ]
Tran, LT [1 ]
Spence, JD [1 ]
机构
[1] UNIV WESTERN ONTARIO, DEPT PHARMACOL & TOXICOL, LONDON, ON N6A 3K7, CANADA
关键词
D O I
10.1016/S0009-9236(96)90163-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To investigate a potentially marked effect by erythromycin on felodipine pharmacokinetics, to characterize the mechanism, and to compare the interaction with that between grapefruit juice and felodipine, Methods: Felodipine, 10 mg extended release, was administered with 250 mi water, 250 mg erythromycin, or 250 mi grapefruit juice in a randomized crossover study of 12 healthy men. Erythromycin base, 250 mg four times a day, was started the day before and continued on that study day, Pharmacokinetic values of felodipine, the primary metabolite dehydrofelodipine, and the major secondary derivative M3 metabolite were studied. Results: Compared with water, erythromycin produced severalfold higher felodipine area under the plasma drug concentration-time profile (AUG), plasma peak drug concentrations (C-max), and apparent elimination half-life (t(1/2)); however, the effect was variable among individuals. Erythromycin augmented dehydrofelodipine AUC, C-max, and t(1/2) but decreased dehydrofelodipine/felodipine ratios. The AUC of the M3 metabolite and the M3 metabolite/dehydrofelodipine ratios were reduced, These findings support inhibition of both metabolic pathways likely mediated by CPP3A4. Grapefruit juice produced similar mean effects but did not prolong felodipine or dehydrofelodipine t(1/2). Individually, felodipine AUC with erythromycin was greater than or similar to that with grapefruit juice. Relative felodipine AUC (erythromycin compared with grapefruit juice) correlated with relative felodipine C-max but not with relative felodipine t(1/2), suggesting felodipine AUC differed between these treatments, mainly from factors affecting presystemic drug elimination. Conclusions: Erythromycin produced an important pharmacokinetic interaction with felodipine by inhibition of drug metabolism, Although erythromycin and grapefruit juice shared a common mechanism, erythromycin likely reduced felodipine biotransformation at the gut wall and liver, whereas single-dose grapefruit juice had an effect mainly at the gut wall.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 29 条
[1]  
Ahnoff M, 1984, J Pharm Biomed Anal, V2, P519, DOI 10.1016/0731-7085(84)80055-2
[2]  
BAILEY DG, 1995, BRIT J CLIN PHARMACO, V40, P135
[3]   GRAPEFRUIT JUICE AND DRUGS - HOW SIGNIFICANT IS THE INTERACTION [J].
BAILEY, DG ;
ARNOLD, JMO ;
SPENCE, JD .
CLINICAL PHARMACOKINETICS, 1994, 26 (02) :91-98
[4]   GRAPEFRUIT JUICE FELODIPINE INTERACTION - MECHANISM, PREDICTABILITY, AND EFFECT OF NARINGIN [J].
BAILEY, DG ;
ARNOLD, JMO ;
MUNOZ, C ;
SPENCE, JD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (06) :637-642
[5]   INTERACTION OF CITRUS JUICES WITH FELODIPINE AND NIFEDIPINE [J].
BAILEY, DG ;
SPENCE, JD ;
MUNOZ, C ;
ARNOLD, JMO .
LANCET, 1991, 337 (8736) :268-269
[6]   OPTIMAL FELODIPINE DOSE WHEN COMBINED WITH METOPROLOL IN ARTERIAL-HYPERTENSION - A SWEDISH MULTICENTER STUDY WITHIN PRIMARY HEALTH-CARE [J].
BRUN, J ;
FROBERG, L ;
KRONMANN, P ;
OLSSON, LB ;
SKOOG, P ;
TYGESEN, G ;
BENGTSSON, C ;
SCHERSTEN, B ;
TIBBLIN, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 :S60-S64
[7]   DISPOSITION OF INTRAVENOUS AND ORAL CYCLOSPORINE AFTER ADMINISTRATION WITH GRAPEFRUIT JUICE [J].
DUCHARME, MP ;
WARBASSE, LH ;
EDWARDS, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (05) :485-491
[8]  
EDGAR B, 1992, EUR J CLIN PHARMACOL, V42, P313
[9]   FELODIPINE KINETICS IN HEALTHY-MEN [J].
EDGAR, B ;
REGARDH, CG ;
JOHNSSON, G ;
JOHANSSON, L ;
LUNDBORG, P ;
LOFBERG, I ;
RONN, O .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (02) :205-211
[10]   DETERMINATION OF 4 CARBOXYLIC-ACID METABOLITES OF FELODIPINE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
GABRIELSSON, M ;
HOFFMANN, KJ ;
REGARDH, CG .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 573 (02) :265-274